Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > By Monday... news will have had more time to be pondered.
View:
Post by menoalittle on Jun 07, 2024 3:55pm

By Monday... news will have had more time to be pondered.

Perhaps it'll make things a bit more interesting...
Comment by Oilminerdeluxe on Jun 07, 2024 4:23pm
Anyone else receive the survey today from the CC? I got the feeling they are fishing for people with funds to spare.  Pretty simple way of finding out actually. Whenever the next financing comes, I hope it is the last one before the BTD, which should make it a whole lot easier to raise bigger bucks. At least in a normal world.
Comment by toade1313 on Jun 07, 2024 4:53pm
Was that the one that asked: To break even on your Theralase investment I need Theralase to go up by 1) 50%, 2) 100%, 3) 200%, 4) 300%, 5) hell I need at least a 10 banger
Comment by chry200030 on Jun 07, 2024 5:31pm
Patience required. This is still a work in progress. If they are successful, I'm expecting a "lot" more than a '10' bagger.
Comment by plantrader on Jun 08, 2024 6:06pm
I think so far someone predicted the news last week should make the stock run to $2 which is around $600M? It's only been a few days so far but it's gone nowhere as usual. I've seen many predictions of multi $billions market cap being warranted for those who hang in there. But there is a massive amount of delivery and execution that has to happen in order to get there. All things ...more  
Comment by chry200030 on Jun 08, 2024 6:20pm
IB buyout... no deal.  It is worth a lot more than that... Let's be patient here.... it's all coming togrether, but it will take a bit of time.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250